Harbour BioMed Appoints Raymond Zheng As Chief Business Officer
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology...
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology...
October 31, 2024 – Friisberg & Partners International has added Sabine Pirkner to its executive board as chief business development strategy...
Jeffrey Ratliff appointed as Takeuchi-US Director of Sales & Marketing, taking over from retiring Henry Lawson. With 25 years of...
DULLES, Va., Oct. 2, 2024 /PRNewswire/ -- Nightwing, the intelligence solutions company defining the edge of the possible for national...
Michael Constantino NEW YORK–(BUSINESS WIRE)–First Eagle Investments is pleased to announce the appointment of Michael Constantino as the firm’s new...
Rami Daoud, M.B.A. Affinia Therapeutics, an innovative company with a proprietary platform pioneering a shift to a new class of...
Amid the passing of founder and CEO, Dinesh Khaladkar, eQ remains committed to client service and its corporate vision of...
PETACH TIKVA, Israel, Sept. 9, 2024 /PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions...
M2i Global, Inc. (OTCQB:MTWO), a company specializing in global critical minerals supply chains, has appointed...